Neuro-Oncology
Brain metastases: considerations for surgical and radiosurgical treatment
Dec. 15, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(a) Organophosphate structural backbone of Novichok agents. R=alkyl, alkoxy, aklylamino, or fluorine. X=halogen (F, Cl, Br) or pseudohalogen (CN). (b) Chemical structure of A-234 as described by Mirzayanov (Smithson et al 1995; Mirzayanov 2008). (c) Chemical structure of A-234 as described by Hoenig and Ellison (Hoenig 2006; Ellison 2008).
(Source: Chai PR, Hayes BD, Erickson TB, Boyer EW. Novichok agents: a historical, current, and toxicological perspective. Toxicol Commun 2018;2[1]:45-8. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)
References cited:
Ellison DH. Handbook of Chemical and Biological Warfare Agents. 2. Boca Raton, FL: Taylor and Francis Group, 2008.
Hoenig SL. Compendium of Chemical Warfare Agents. New York, NY: Springer, 2006.
Mirzayanov VS. State Secrets: An Insider's Chronicle of the Russian Chemical Weapons Program. Denver: Outskirts Press, 2008.
Smithson AE, Mirzayanov VS, Lajoie R, Krepon M. Chemical Weapons Disarmament in Russia: Problems and Prospects. Report number 17. Washington, DC: The Henry L. Stimson Center; 1995:1-83.